ANTILIPIDEMIC DRUGS PDF
Hypolipidemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used in the treatment of high levels of fats (lipids), such as cholesterol, in the blood (hyperlipidemia). They are called lipid-lowering drugs . The sites of action of several antihyperlipidemic drugs are shown. .. on LDL cholesterol, they are often combined with other antilipidemic drugs for treatment of. Antihyperlipidemic Drugs Dr Ahmed Bader Faculty of Medicine, Menoufiya University, Egypt.
|Genre:||Health and Food|
|Published (Last):||18 August 2007|
|PDF File Size:||18.59 Mb|
|ePub File Size:||5.77 Mb|
|Price:||Free* [*Free Regsitration Required]|
The dtugs of the approval was similar to the approval given to the Regeneron drug, Praluent alirocumabwhich was approved for patients with cardiovascular disease and those with HeFH.
Major focus lies on approaches to LDL-lowering drugs superior to statins with regard to efficacy, safety, and patient compliance and on approaches modifying plasma levels and functionality of HDL particles based on the clinically validated inverse relationship between high-plasma HDL levels and the risk for CVD.
Atherosclerosis is the abnormal accumulation of lipids and products resulting from an inflammatory response in the walls of arteries, and is the leading cause of death in the Western world. Jump to a Section Antihyperlipidemic Drugs: To view content sources and attributions, please refer to our editorial policy.
Antilipidemic Drug Therapy Today and in the Future.
This page was last edited on 23 Februaryat They may antilipudemic in both their impact on the cholesterol profile and adverse effects.
Macrophages in arterial walls use scavenger receptors to take up circulating lipoproteins, especially particles with apolipoproteins that have been modified by free radicals.
The armamentarium for the treatment of dyslipidemia today comprises six different modes of action with overall around 24 different drugs. For example, some may lower the “bad cholesterol” low density lipoprotein LDL more so than others, while others may preferentially increase high density lipoprotein HDL”the anhilipidemic cholesterol”. In some cases, lowering serum lipid concentrations has been shown to prevent the sequelae of atherosclerosis and decrease mortality in patients with a history of cardiovascular disease and hyperlipidemia.
Clinical Sports Medicine Collection. The promising clinical results of several novel drug candidates, particularly anttilipidemic LDL cholesterol lowering with monoclonal antibodies raised against PCSK9, may indicate more than a decade after the statins, the entrance of new breakthrough therapies to treat lipid disorders. You can also find results for a single author or contributor. Sign in via OpenAthens.
About MyAccess If your institution subscribes to this resource, and you don’t have a MyAccess Profile, please contact your library’s reference desk for information on how to gain access to this resource from off-campus.
Subscribe to receive email notifications whenever new articles are published. Although the drugs are generally safe and effective, adverse effects include drug—drug interactions and antilipidemjc toxic reactions in skeletal muscle and the liver. Antiipidemic identification of abbreviations of the lipoproteins, some drug classes, and additional discussion, see text. Search Advanced search allows to you precisely focus your query.
Please enter Password Forgot Username? The drugs are more potent than traditional cholesterol-lowering statin drugs, such as Pfizer Inc’s Lipitor. Lipoproteins are composed of a lipid core surrounded by apolipoproteins that regulate the uptake and off-loading of lipids and interactions with cell membrane receptors. Anticancer agents Antimetabolites Alkylating Antilipidemid poisons Antineoplastic Topoisomerase inhibitors.
The five drug classes discussed in this chapter Figure 26—1 are antilopidemic to decrease serum concentrations of lipids in the blood hyperlipidemia and to prevent or reverse associated atherosclerosis, or, in the case of hypertriglyceridemia, prevent pancreatitis. Receptor-mediated uptake is a carefully regulated process that protects cells from being overloaded with lipids.
Lipid-lowering agent – Wikipedia
Pop-up div Successfully Displayed This div only appears when the trigger link is hovered over. Please enter User Name. Heart attacks, angina pectoris, peripheral arterial disease, and strokes are common sequelae of atherosclerosis. By reducing the LDL cholesterol, they can prevent both the primary and secondary symptoms of coronary heart disease.
Views Read Edit View history. Repatha is given as a mg injection every other week or as a monthly injection of mg. In contrast, uptake by scavenger receptors is an unregulated process that can overwhelm the ability of a cell to sequester potentially toxic lipids safely.
Sign in via Shibboleth. Some antihyperlipidemic agents aim to lower the levels of low-density lipoprotein LDL cholesterol, some reduce triglyceride levels, and some help raise the high-density lipoprotein HDL cholesterol. It was also approved for patients with cardiovascular disease including heart attack or stroke, who require additional cholesterol lowering. These classes are based on the mechanisms of action of these drugs.